AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS
Go back to AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS| ALLIANCEBERNSTEIN HOLDING, L.P. (NYSE: AB) | Delayed: 35.78 -0.18 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.96 | 52 Week High | $26.24 | |||
| Open | $35.98 | 52 Week Low | $16.11 | |||
| Day High | $36.10 | P/E | 21.05 | |||
| Day Low | $35.55 | EPS | $1.70 | |||
| Volume | 309,300 | |||||
